Industry Specialties: Manufacturers and Distributors
Infor Cloudsuite Industrial (Syteline) is not currently ranked among the top Lean Manufacturing Software according to the latest available data collected by SelectHub. Compare the leaders with our In-Depth Report.
With Copley, we now have one system that handles all of our business requirements, including our need for data integrity as well as our documentation for GMP risk areas, leading to an improvement in our overall business processes.
We feel the efficiencies we have gained with the Infor and Copley FDA solution will accelerate our growth trajectory, while maintaining our core values of quality and delivery performance.
Working with Copley and Gradient to implement Infor CSI, we are now better aligned with our corporate team and have been able to improve scheduling, inventory management and order fulfillment for our customers. The results have been tremendous, with improved financial reporting for our executive team and better decision-making for the company.
Here are the most similar products to Infor Cloudsuite Industrial (Syteline).
A note from The Copley Consulting Group
The Copley Consulting Group has 30 years of experience successfully implementing Infor CloudSuite™ Industrial (SyteLine) ERP for hundreds of midmarket manufacturing companies. As one of Infor’s premier Gold Level Channel Partners, Copley has assembled a nationwide team of dedicated service professionals committed to improving the operational efficiencies of our customers.
Infor CloudSuite Industrial (CSI) is end-to-end ERP solution for manufacturers giving them the tools needed to manage complex value chains and fast-paced product launches, while shortening cycle times and easily managing product configurations.
Infor has named Copley their micro-vertical specialist for the Life Sciences and Medical Device industries. With our expertise in FDA regulated markets, we have helped some of the leading medical device and biotech firms remain compliant and bring products to market quickly and with less regulatory risk.
- Lisa Joseph, Vice President of Corporate Strategy